HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eva Alonso Selected Research

Cyclophilin C

1/2022Increase of serum cyclophilin C levels in the follow-up of coronary artery disease: A biomarker and possible clinical predictor.
1/2019High Serum Cyclophilin C levels as a risk factor marker for Coronary Artery Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eva Alonso Research Topics

Disease

10Alzheimer Disease (Alzheimer's Disease)
01/2019 - 05/2010
6Neuroblastoma
01/2021 - 09/2008
5Inflammation (Inflammations)
01/2021 - 01/2016
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 01/2011
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2019
4Neuroinflammatory Diseases
01/2021 - 10/2018
3Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2019
2Lymphoma (Lymphomas)
01/2022 - 01/2017
2Neoplasms (Cancer)
03/2021 - 01/2016
2Ciguatera Poisoning (Ciguatera)
09/2012 - 04/2011
1Adenocarcinoma
03/2021
1Acute Coronary Syndrome
01/2021
1Q Fever (Fever, Q)
01/2021
1Neutropenia
12/2020
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2020
1Necrosis
01/2019
1Shellfish Poisoning
02/2016
1Dementia (Dementias)
03/2013
1Mastocytosis
01/2013
1Heart Arrest (Cardiac Arrest)
11/2003
1Acute Kidney Injury (Acute Renal Failure)
10/2003
1Pneumonia (Pneumonitis)
10/2003

Drug/Important Bio-Agent (IBA)

7Amyloid beta-PeptidesIBA
01/2019 - 05/2010
3Cyclophilins (Cyclophilin)IBA
01/2021 - 01/2019
3AntioxidantsIBA
01/2021 - 10/2016
2Cyclophilin CIBA
01/2022 - 01/2019
2Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2021
2DNA (Deoxyribonucleic Acid)IBA
03/2021 - 01/2021
2Neuroprotective AgentsIBA
01/2021 - 01/2020
2Cyclophilin AIBA
01/2021 - 01/2016
2Peptides (Polypeptides)IBA
07/2020 - 01/2019
2LipopolysaccharidesIBA
01/2020 - 10/2018
2gambierolIBA
01/2017 - 09/2012
2Amyloid (Amyloid Fibrils)IBA
01/2017 - 07/2013
2Sodium Channels (Sodium Channel)IBA
02/2016 - 04/2011
213-desmethylspirolide CIBA
03/2013 - 12/2011
1sphaerodactylomelolIBA
03/2021
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
03/2021
1Caspase 9IBA
03/2021
1PhosphatidylserinesIBA
03/2021
1jasplakinolideIBA
01/2021
1InterleukinsIBA
01/2021
1Cell Surface ReceptorsIBA
01/2021
1Biosimilar PharmaceuticalsIBA
12/2020
1Filgrastim (Neupogen)FDA Link
12/2020
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
12/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2020
1cis-trans-IsomerasesIBA
10/2020
1Biological ProductsIBA
07/2020
1gracilin LIBA
05/2020
1Proteins (Proteins, Gene)FDA Link
01/2019
1gracilin aIBA
01/2019
1MacrolidesIBA
01/2019
1ImmunophilinsIBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2017
1sarain AIBA
10/2017
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2017
1Voltage-Gated Sodium ChannelsIBA
02/2016
1CalciumIBA
01/2015
1Pharmaceutical PreparationsIBA
01/2014
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
07/2013
1Protein Kinase CIBA
07/2013
1Protein Isoforms (Isoforms)IBA
07/2013
1diethylstilbestrol monophosphate (PDES)IBA
07/2013
1yessotoxinIBA
07/2013
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
03/2013
1Aurora KinasesIBA
01/2013
1Potassium Channels (Potassium Channel)IBA
09/2012
1CiguatoxinsIBA
04/2011
1Cholinergic Antagonists (Anticholinergics)IBA
01/2011
1gymnodimineIBA
01/2011
1CaspasesIBA
09/2008
1Biotin (Vitamin H)FDA Link
09/2008
1EstersIBA
09/2008
1Carboxylic AcidsIBA
09/2008
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2003
1AntigensIBA
10/2003

Therapy/Procedure

2Stem Cell Transplantation
01/2022 - 01/2017
1Combination Drug Therapy (Combination Chemotherapy)
12/2020
1Therapeutics
09/2012
1Aftercare (After-Treatment)
09/2008
1Resuscitation
11/2003
1Secondary Prevention
11/2003
1Artificial Respiration (Mechanical Ventilation)
10/2003